Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|6|659-666

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.6, 2015-06, pp. : 659-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of human cytomegalovirus infection and T‐cell response in patients with psoriasis before and during antitumour necrosis factor‐α therapy

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : e323-e324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 333-334

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serology and ulcerative colitis behavior

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 64-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic dose tailoring in Crohn disease

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 170-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite